Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Sep;21(9):1033-1042.
doi: 10.1016/j.jval.2018.06.017. Epub 2018 Aug 8.

Methodological Issues in Assessing the Economic Value of Next-Generation Sequencing Tests: Many Challenges and Not Enough Solutions

Kathryn A Phillips  1 , Patricia A Deverka  2 , Deborah A Marshall  3 , Sarah Wordsworth  4 , Dean A Regier  5 , Kurt D Christensen  6 , James Buchanan  4
Affiliations
Review

Methodological Issues in Assessing the Economic Value of Next-Generation Sequencing Tests: Many Challenges and Not Enough Solutions

Kathryn A Phillips et al. Value Health. 2018 Sep.

Erratum in

  • Correction.
    [No authors listed] [No authors listed] Value Health. 2019 Mar;22(3):383. doi: 10.1016/j.jval.2018.11.004. Epub 2018 Nov 27. Value Health. 2019. PMID: 30832980 No abstract available.

Abstract

Background: Clinical use of next-generation sequencing (NGS) tests has been increasing, but few studies have examined their economic value. Several studies have noted that there are methodological challenges to conducting economic evaluations of NGS tests.

Objective: Our objective was to examine key methodological challenges for conducting economic evaluations of NGS tests, prioritize these challenges for future research, and identify how studies have attempted solutions to address these challenges.

Methods: We identified challenges for economic evaluations of NGS tests using prior literature and expert judgment of the co-authors. We used a modified Delphi assessment to prioritize challenges, based on importance and probability of resolution. Using a structured literature review and article extraction we then assessed whether published economic evaluations had addressed these challenges.

Results: We identified 11 challenges for conducting economic evaluations of NGS tests. The experts identified three challenges as the top priorities for future research: complex model structure, timeframe, and type of analysis and comparators used. Of the 15 published studies included in our literature review, four studies described specific solutions relevant to five of the 11 identified challenges.

Conclusions: Major methodological challenges to economic evaluations of NGS tests remain to be addressed. Our results can be used to guide future research and inform decision-makers on how to prioritize research on the economic assessment of NGS tests.

Keywords: economics; methods development; next-generation sequencing; personalized medicine; precision medicine.

PubMed Disclaimer

Figures

Figure 1:
Figure 1:
PRISMA diagram of included and excluded studies.
See this image and copyright information in PMC

References

    1. Phillips KA, Deverka PA, Hooker GW, et al. Genetic Test Availability And Spending: Where Are We Now? Where Are We Going? Health Aff (Millwood). 2018; 37: 710–16. - PMC - PubMed
    1. Schwarze K, Buchanan J, Taylor JC, et al. Are whole-exome and whole-genome sequencing approaches cost-effective? A systematic review of the literature. Genet Med. 2018; February 15 [Epub ahead of print]. - PubMed
    1. Fugel HJ, Nuijten M, Postma M, et al. Economic Evaluation in Stratified Medicine: Methodological Issues and Challenges. Front Pharmacol. 2016; 7: 113. - PMC - PubMed
    1. Annemans L, Redekop K, Payne K. Current methodological issues in the economic assessment of personalized medicine. Value Health. 2013; 16: S20–6. - PubMed
    1. Lu CY. Economic evaluation of whole-genome sequencing in healthy individuals: what can we learn from CEAs of whole-body CT screening? Genet Med. 2016; 18: 103–4. - PubMed

Publication types

MeSH terms